Balthaser Kevin
SEC insider (Form 3/4/5 filer). CIK 0001957554. Chief Financial Officer at Aclaris Therapeutics, Inc. (ACRS). 30 reported Form 4/5 transactions since Sep 2024; latest on Mar 1, 2026. Located in WAYNE, PA.
Companies Balthaser Kevin has filed insider reports for
- Aclaris Therapeutics, Inc. (ACRS): Officer, Chief Financial Officer
Balthaser Kevin
CIK: 0001957554
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Aclaris Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (30 total)
- Mar 1, 2026ACRS
Aclaris Therapeutics, Inc.
ExerciseDirect2.4K shares- - Mar 1, 2026ACRS
Aclaris Therapeutics, Inc.
Tax PaymentDirect677 shares at avg. $2.87$2K - Feb 3, 2026ACRS
Aclaris Therapeutics, Inc.
Tax PaymentDirect6.4K shares at avg. $3.47$22K - Feb 3, 2026ACRS
Aclaris Therapeutics, Inc.
ExerciseDirect22K shares- - Feb 2, 2026ACRS
Aclaris Therapeutics, Inc.
AwardDirectRestricted Stock Units
99.1K shares- - Feb 2, 2026ACRS
Aclaris Therapeutics, Inc.
AwardDirectEmployee Stock Option (Right to Buy)
346.8K shares- - Feb 1, 2026ACRS
Aclaris Therapeutics, Inc.
ExerciseDirect14.8K shares- - Feb 1, 2026ACRS
Aclaris Therapeutics, Inc.
Tax PaymentDirect5K shares at avg. $3.51$17K - Jan 2, 2026ACRS
Aclaris Therapeutics, Inc.
Tax PaymentDirect4.5K shares at avg. $2.88$13K - Jan 2, 2026ACRS
Aclaris Therapeutics, Inc.
ExerciseDirect13.2K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Mar 1, 2026 | ACRS Aclaris Therapeutics, Inc. | Exercise | 2,375 | - | $0 | Direct |
| Mar 1, 2026 | ACRS Aclaris Therapeutics, Inc. | Tax Payment | 677 | $2.87 | $1,943 | Direct |
| Feb 3, 2026 | ACRS Aclaris Therapeutics, Inc. | Tax Payment | 6,449 | $3.47 | $22,378 | Direct |
| Feb 3, 2026 | ACRS Aclaris Therapeutics, Inc. | Exercise | 22,025 | - | $0 | Direct |
| Feb 2, 2026 | ACRS Aclaris Therapeutics, Inc. | Award Restricted Stock Units | 99,100 | - | - | Direct |
| Feb 2, 2026 | ACRS Aclaris Therapeutics, Inc. | Award Employee Stock Option (Right to Buy) | 346,800 | - | - | Direct |
| Feb 1, 2026 | ACRS Aclaris Therapeutics, Inc. | Exercise | 14,750 | - | $0 | Direct |
| Feb 1, 2026 | ACRS Aclaris Therapeutics, Inc. | Tax Payment | 4,984 | $3.51 | $17,494 | Direct |
| Jan 2, 2026 | ACRS Aclaris Therapeutics, Inc. | Tax Payment | 4,461 | $2.88 | $12,848 | Direct |
| Jan 2, 2026 | ACRS Aclaris Therapeutics, Inc. | Exercise | 13,200 | - | $0 | Direct |
1-10 of 30 transactions